We use a few cookies

Essential cookies keep the library working. With your permission, we'd also like to use analytics to see what's useful and improve the experience. Read our Privacy Policy or Cookie Policy.

Skip to main content
Home/e-Resources/Biotechnology/Carbohydrate-Based Adjuvants for Vaccine Production

Checking your access to this record.

Abstract & Overview

Addition of adjuvants is a generally recognized method of enhancing the immunogenicity of vaccines. There is a large variety of adjuvants, therefore the choice of an adjuvant is based on the comparison of adjuvants efficacy in animal models, as well as assessment of their safety and tolerability. There are many different groups of substances that may have adjuvant properties, but relatively little attention is paid to carbohydrate-based adjuvants, despite the fact that they are compatible with live vector vaccines, safe, well tolerated, and their production is not laborious. Thanks to these advantages the use of these particular adjuvants in combination with any type of vaccine, including vector vaccines and DNA vaccines, may be most appropriate and promising. This review examines various types of carbohydrate adjuvants and the mechanisms that determine their efficacy.

Cite this record

Т. М. Сабирова, Tamara K. Dzagurova, Aydar A. Ishmukhametov, M. S. Egorova, Maria V. Balovneva (2018). Carbohydrate-Based Adjuvants for Vaccine Production. Biological Products Prevention Diagnosis Treatment, 18(2), 81–91. https://doi.org/10.30895/2221-996x-2018-18-2-81-91

Copy in another style

Сабирова, Т. М., Dzagurova, T. K., Ishmukhametov, A. A., Egorova, M. S., & Balovneva, M. V. (2018). Carbohydrate-Based Adjuvants for Vaccine Production. Biological Products Prevention Diagnosis Treatment, 18(2), 81–91. https://doi.org/10.30895/2221-996x-2018-18-2-81-91
Author names are used as deposited, so check their order before you submit.

Metadata is harvested from open-access indexes and can be incomplete. Check a citation against the published version before relying on it — see our open access & attribution policy.